Internal Medicine, Endocrinology, Diabetes, & Metabolism · Scarborough, ME
NPI
1942695093
Since 2015
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
175 US Route 1
Scarborough, ME, 04074
Phone (207) 396-7700
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
363 services
Medicare patients, 2024
154
Average age 73
Drug cost, 2024
$1.3M
1,869 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca H Leary was code 99214 (office e&m - established), 166 times for 125 patients. In total Rebecca H Leary billed 363 services in 14 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 166 | 125 | $69.97 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 128 | 107 | $11.72 | $1,501 |
| 95251 Test - Miscellaneous | Office | 31 | 16 | $26.57 | $824 |
By year: 2022 $17K for 255 services; 2023 $20K for 292 services; 2024 $17K for 363 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca H Leary prescribed most often to Medicare patients was Levothyroxine Sodium, with 450 prescriptions and refills. In total Rebecca H Leary wrote 1,869 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 450 | 1,243 | 122 | $5,114 |
| Jardiance Empagliflozin | 93 | 223 | 28 | $131K |
| Ozempic Semaglutide | 88 | 159 | 23 | $147K |
| Metformin Hcl Er Metformin Hcl | 87 | 229 | 28 | $1,899 |
| Methimazole Generic | 82 | 234 | 28 | $724 |
| Metformin Hcl Generic | 64 | 160 | 18 | $514 |
| Trulicity Dulaglutide | 59 | 100 | 12 | $100K |
| Hydrocortisone Generic | 56 | 88 | 15 | $4,578 |
| Mounjaro Tirzepatide | 53 | 55 | 11 | $56K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 46 | 115 | 19 | $6,820 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 38 | 78 | 12 | $16K |
| Prednisone Generic | 38 | 93 | Under 11 | $302 |
| Tresiba Flextouch U-200 Insulin Degludec | 38 | 93 | Under 11 | $44K |
| Novolog Flexpen Insulin Aspart | 37 | 90 | 16 | $16K |
| Glipizide Er Glipizide | 36 | 107 | 11 | $556 |
Brand drugs: 847 claims; generic drugs: 917 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rebecca H Leary were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.